HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tissue factor pathway inhibitor 2 (TFPI2) is frequently silenced by aberrant promoter hypermethylation in gastric cancer.

Abstract
Aberrant methylation of promoter CpG islands is associated with transcriptional inactivation of tumor-suppressor genes in cancer. TFPI2, a Kunitz-type serine proteinase inhibitor, has been identified as a putative tumor-suppressor gene from genome-wide screening for aberrant methylation, using a microarray combined with the methyltransferase inhibitor 5-aza-2'-deoxycytidine (5-aza-dCyd) in various types of tumors. We assessed the methylation status of TFPI2 and investigated its expression pattern in human primary gastric cancer (GC) tissues and in GC cell lines. Hypermethylation of the promoter CpG island, which was observed in more or less all of GC cell lines, was prevalent in a high proportion of primary GC tissues (15/18, or 83%), compared with noncancerous (4/18, or 22%) or normal (0/3, or 0%) stomach tissues, and expression of TFPI2 mRNA was reduced in 7 of the 17 primary GC tissues (41%). Moreover, immunohistochemical analyses showed decreased levels of TFPI-2 protein, compared with adjacent noncancerous tissues in 8 of the 20 primary GC tissues examined (40%). TFPI2 mRNA expression was restored in gene-silenced GC cells after treatment with 5-aza-dCyd. Aberrant methylation of TFPI2 promoter CpG island occurred not only in GC cells but also in primary GC tissues at a high frequency, suggesting that epigenetic silencing of TFPI2 may contribute to gastric carcinogenesis.
AuthorsHisashi Takada, Naoki Wakabayashi, Osamu Dohi, Kohichiroh Yasui, Chouhei Sakakura, Shoji Mitsufuji, Masafumi Taniwaki, Toshikazu Yoshikawa
JournalCancer genetics and cytogenetics (Cancer Genet Cytogenet) Vol. 197 Issue 1 Pg. 16-24 (Feb 2010) ISSN: 1873-4456 [Electronic] United States
PMID20113832 (Publication Type: Journal Article)
CopyrightCopyright (c) 2010 Elsevier Inc. All rights reserved.
Chemical References
  • Glycoproteins
  • RNA, Messenger
  • tissue-factor-pathway inhibitor 2
  • Azacitidine
Topics
  • Adult
  • Aged
  • Azacitidine (pharmacology)
  • Cell Line, Tumor
  • CpG Islands
  • DNA Methylation
  • Female
  • Gene Silencing
  • Glycoproteins (genetics)
  • Humans
  • Male
  • Middle Aged
  • Promoter Regions, Genetic
  • RNA, Messenger (analysis)
  • Stomach Neoplasms (etiology, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: